Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
MTE17 - Nursing Goes Global - Meeting the Challenges Posed by Mesothelioma
- Type: Meet the Expert (ticketed session)
- Track: Mesothelioma
- Presentations: 5
- Moderators:B. Ivimey
- Coordinates: 10/29/2013, 07:00 - 08:00, Bayside 201 - 203, Level 2
-
+
MTE17.0 - N/A - Chair Intro
07:00 - 07:05
- Abstract
No abstract available for this presentation
-
+
MTE17.1 - The Driving Force of Social Networking
07:05 - 07:20 | Author(s): M. Hesdorffer
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MTE17.2 - Preparing to Meet the Growing Need
07:20 - 07:35 | Author(s): L. Darlison
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MTE17.3 - Surgical Options and Global Differences
07:35 - 07:50 | Author(s): J. McLean
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MTE17.4 - Discussion
07:50 - 08:00 | Author(s): N. n/a
- Abstract
No abstract available for this presentation
-
+
MTE21a - Genomics in Lung Cancer
- Type: Meet the Expert (ticketed session)
- Track: Pathology
- Presentations: 0
- Moderators:N. n/a
- Coordinates: 10/29/2013, 07:00 - 08:00, Bayside 204 A+B, Level 2
-
+
PL03 - Presidential Symposium Including Top Rated Abstracts
- Type: Plenary Session
- Track:
- Presentations: 8
- Moderators:M. Boyer
- Coordinates: 10/29/2013, 08:15 - 09:45, Plenary Hall, Ground Level
-
+
PL03.01 - Lung cancer probability in subjects with CT-detected pulmonary nodules
08:15 - 08:27 | Author(s): N. Horeweg
- Abstract
Loading... -
+
PL03.02 - DISCUSSANT
08:27 - 08:37 | Author(s): C. Berg
- Abstract
No abstract available for this presentation
-
+
PL03.03 - MesoVATS: A multi-centre randomised controlled trial of video assisted thoracoscopic pleurectomy versus talc pleurodesis in malignant pleural mesothelioma
08:37 - 08:49 | Author(s): R.C. Rintoul
- Abstract
Loading... -
+
PL03.04 - DISCUSSANT
08:49 - 08:59 | Author(s): V. Rusch
- Abstract
No abstract available for this presentation
-
+
PL03.05 - An intergroup randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) chemoradiotherapy (CRT) +/- cetuximab (cetux) for stage III non-small cell lung cancer (NSCLC): Results on cetux from RTOG 0617
08:59 - 09:11 | Author(s): J. Bradley
- Abstract
Loading... -
+
PL03.06 - DISCUSSANT
09:11 - 09:21 | Author(s): J. Jassem
- Abstract
No abstract available for this presentation
-
+
PL03.07 - Treatment with Therapies Matched to Oncogenic Drivers Improves Survival in Patients with Lung Cancers: Results from The Lung Cancer Mutation Consortium (LCMC)
09:21 - 09:33 | Author(s): M.G. Kris
- Abstract
Loading... -
+
PL03.08 - DISCUSSANT
09:33 - 09:43 | Author(s): B. Solomon
- Abstract
No abstract available for this presentation
-
+
P2.01 - Poster Session 2 - Cancer Biology
- Type: Poster Session
- Track: Biology
- Presentations: 26
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.01-001 - Deregulated Interleukin-6 Signaling Suppresses Lung Tumourigenesis in Mice Induced by Nicotine-derived Nitrosamine Ketone
09:30 - 09:30 | Author(s): S. Ruwanpura
- Abstract
Loading... -
+
P2.01-002 - Targeting chaperone activity and chaperone expression in human lung cancer cells sensitizes them to chemotherapy and radiotherapy
09:30 - 09:30 | Author(s): A. Kabakov
- Abstract
Loading... -
+
P2.01-003 - Modulation of Cisplatin Activity in NSCLC by KRAS Mutants: Role of Specific Mutations at Codon 12
09:30 - 09:30 | Author(s): E. Caiola
- Abstract
Loading... -
+
P2.01-004 - Type of P53 mutation influences oncogenic potential and spectrum of associated K-ras mutations in lung specific transgenic mice.
09:30 - 09:30 | Author(s): W. Duan
- Abstract
Loading... -
+
P2.01-005 - Diagnostic application of 9p21 Homozygous and Heterozygous Deletion Detected by Fluorescence in Situ Hybridization (FISH) and p16 Real-Time PCR in Malignant Mesothelioma
09:30 - 09:30 | Author(s): M. Hamasaki
- Abstract
Loading... -
+
P2.01-006 - Novel small compounds targeting cancer stem cells of non-small cell lung cancer
09:30 - 09:30 | Author(s): C. Yang
- Abstract
Loading... -
+
P2.01-007 - Distinct characteristics of small cell lung cancer (SCLC) correlate with central or peripheral origin - microarray analysis of snap frozen tissue samples.
09:30 - 09:30 | Author(s): E. Miyauchi
- Abstract
Loading... -
+
P2.01-008 - Significance of Cancer-Associated Fibroblasts in the Regulation of Gene Expression in the Leading Cells of Invasive Lung Cancer
09:30 - 09:30 | Author(s): J. An
- Abstract
Loading... -
+
P2.01-009 - Altered expression of aPKC lambda/iota and Lgl2 correlates with invasion and metastasis in lung adenocarcinoma
09:30 - 09:30 | Author(s): N. Imamura
- Abstract
Loading... -
+
P2.01-010 - A model of chronic inflammation affects the invasive capacity and induces several hallmarks of cancer in a normal bronchial epithelial cell line
09:30 - 09:30 | Author(s): A. Baird
- Abstract
Loading... -
+
P2.01-011 - The IL-23 family may be a novel therapeutic target in non small cell lung cancer
09:30 - 09:30 | Author(s): A. Baird
- Abstract
Loading... -
+
P2.01-012 - Pequi fruit (Caryocar brasiliense Camb) protects against oxidative stress induced by urethane in a experimental model of lung cancer.
09:30 - 09:30 | Author(s): N. Colombo
- Abstract
Loading... -
+
P2.01-013 - MicroRNA expression of non-terminal respiratory unit type lung adenocarcinoma
09:30 - 09:30 | Author(s): M. Kim
- Abstract
Loading... -
+
P2.01-014 - Fundamental examination in the plasticity of Cancer stem-like cell (CSC) / Cancer-initiating cell (CIC) in Lung Cancer
09:30 - 09:30 | Author(s): S. Hiroshi
- Abstract
Loading... -
+
P2.01-015 - Gene expression of MAGE-A3 and PRAME tumor antigens and EGFR mutational status in lung adenocarcinoma in a German center
09:30 - 09:30 | Author(s): N.F. Delahaye
- Abstract
Loading... -
+
P2.01-016 - Targeting the PI3K-mTOR-NFκB pathway to overcome cisplatin resistance in NSCLC.
09:30 - 09:30 | Author(s): S. Heavey
- Abstract
Loading... -
+
P2.01-017 - Gene expression of MAGE-A3 tumor antigen and EGFR mutational status in Chinese NSCLC patients
09:30 - 09:30 | Author(s): Y. Wu
- Abstract
Loading... -
+
P2.01-018 - Defective DNA damage response in lungs of asthmatics: A possible link to lung cancer?
09:30 - 09:30 | Author(s): R. Rehman
- Abstract
Loading... -
+
P2.01-019 - Heterogeneity of EGFR mutation detected in a patient treated with gefitinib
as neo-adjuvant chemotherapy09:30 - 09:30 | Author(s): K. Mizoguchi
- Abstract
Loading... -
+
P2.01-020 - Down-regulation of Somatostatin Receptor 2 decreases cell proliferation in Lung Cancer
09:30 - 09:30 | Author(s): M. Hoeksema
- Abstract
Loading... -
+
P2.01-021 - AMP Converted from Intracellularly Transported Adenosine Upregulates p53 Expression to Induce Malignant Pleural Mesothelioma Cell Apoptosis
09:30 - 09:30 | Author(s): Y. Nogi
- Abstract
Loading... -
+
P2.01-022 - Treatment with EGCG in NSCLC leads to decreasing interstitial fluid pressure and hypoxia to improve chemotherapy efficacy through rebalance of Ang-1 and Ang-2
09:30 - 09:30 | Author(s): P.B. Deng
- Abstract
Loading... -
+
P2.01-023 - ER homeostasis and motility of NSCLC cell lines can be therapeutically targeted with combined Hsp90 and HDAC inhibitors.
09:30 - 09:30 | Author(s): V. Zismanov
- Abstract
Loading... -
+
P2.01-024 - Quantitative determination of EGFR gene aberrant methylation in non small cell lung cancer (NSCLC): a comparative analysis in tumor tissue, normal lung tissue, peripheral blood, sputum and bronchial aspirate. Correlation with clinical variables.
09:30 - 09:30 | Author(s): M.A. Cobo Dols
- Abstract
Loading... -
+
P2.01-025 - Differential miRNA Expression in Neuroendocrine Tumours of the Lung
09:30 - 09:30 | Author(s): A. Fisseler-Eckhoff
- Abstract
Loading... -
+
P2.01-026 - "EGFR" gene mutation in advanced non small cell lung cancer-a case series
09:30 - 09:30 | Author(s): A. Rashid
- Abstract
Loading...
-
+
P2.02 - Poster Session 2 - Novel Cancer Genes and Pathways
- Type: Poster Session
- Track: Biology
- Presentations: 21
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.02-001 - MED12, a component of the transcriptional MEDIATOR complex, and STAT3 influence outcome to platinum-based chemotherapy in patients (p) with advanced non-small-cell lung cancer (NSCLC)
09:30 - 09:47 | Author(s): D. Morales-Espinosa
- Abstract
Loading... -
+
P2.02-002 - Stratifin expressed in early invasive lung adenocarcinoma functionally enhances tumor progression and down-regulates SCFFbw7 ubiquitin ligase activity
09:47 - 10:04 | Author(s): A. Shiba
- Abstract
Loading... -
+
P2.02-003 - DNA methylation and expression patterns in adenocarcinomas of the lung of never-smokers with discordant methylation and expression patterns of homeobox related genes
10:04 - 10:21 | Author(s): A.S. Mansfield
- Abstract
Loading... -
+
P2.02-004 - Erk/MAP-kinase signaling pathway and neuroendocrine differentiation of non-small cell lung cancer
10:21 - 10:38 | Author(s): Y. Chen
- Abstract
Loading... -
+
P2.02-005 - Expression of fibroblast growth factor-9 is associated with poor prognosis of resected non-small cell lung cancer patients
10:38 - 10:55 | Author(s): K. Ohgino
- Abstract
Loading... -
+
P2.02-006 - The selective regulation of EGFR mutants by C-terminus of Hsc70-interacting-protein(CHIP) in lung adenocarcinoma
10:55 - 11:12 | Author(s): C. Chung
- Abstract
Loading... -
+
P2.02-007 - HDGF, ADAM9 involved in a novel pathway of cell growth and invasion of non-small cell lung cancer cells, may become novel molecular staging biomarkers, prognostic and predictive biomarkers of NSCLC
11:12 - 11:29 | Author(s): J. Zhang
- Abstract
Loading... -
+
P2.02-008 - Elevated microsatellite alterations at selected tetra-nucleotide (EMAST) in non-small cell lung cancers - a potential determinant of susceptibility to multiple malignancies
11:29 - 11:46 | Author(s): H. Arai
- Abstract
Loading... -
+
P2.02-009 - Expression of a splicing variant of the CADM1 specific to small cell lung cancer
11:46 - 12:03 | Author(s): S. Kikuchi
- Abstract
Loading... -
+
P2.02-010 - Frequency of ALK Gene Rearrangement in Saudi Lung Cancer
12:03 - 12:20 | Author(s): F.H. Al-Dayel
- Abstract
Loading... -
+
P2.02-011 - Impact of Family History of Cancer on the Incidence of Mutation in Epidermal Growth Factor Receptor Gene in Non-small Cell Lung Cancer Patients
12:20 - 12:37 | Author(s): Y. He
- Abstract
Loading... -
+
P2.02-012 - Long non-coding RNA BC070487 Represses the Novel Tumor Suppressor Gene ZNFX1 During Tobacco-Induced Human Pulmonary Carcinogenesis
12:37 - 12:54 | Author(s): S. Xi
- Abstract
Loading... -
+
P2.02-013 - The importance of immunoregulatory genes in non small cell lung cancer
12:54 - 13:11 | Author(s): E. García
- Abstract
Loading... -
+
P2.02-014 - Discovery of circulating protein biomarkers of lung dysplasia
13:11 - 13:28 | Author(s): R. Ostroff
- Abstract
Loading... -
+
P2.02-015 - Proteomic insights with lung cancer tumors based on histopathologic subtypes and genotypes
13:28 - 13:45 | Author(s): R. Ostroff
- Abstract
Loading... -
+
P2.02-016 - PRMT5, a novel epigenetic target in lung cancers
13:45 - 14:02 | Author(s): G.A. Otterson
- Abstract
Loading... -
+
P2.02-017 - analysis of p53, Rb, c-met, c-kit and PDGF/ in lung carcinoids
14:02 - 14:19 | Author(s): G. Alonso
- Abstract
Loading... -
+
P2.02-018 - the notch/hes1/ascl1 signaling pathway in lung carcinoid
14:19 - 14:36 | Author(s): R. Garcia Campelo
- Abstract
Loading... -
+
P2.02-019 - analysis of p53, Rb, c-met, c-kit and PDGFα/β in lung carcinoids.
14:36 - 14:53 | Author(s): R. Garcia Campelo
- Abstract
Loading... -
+
P2.02-020 - MicroRNA deregulation associated with node positive lung adenocarcinoma
14:53 - 15:10 | Author(s): K.S. Enfield
- Abstract
Loading... -
+
P2.02-021 - Implications of CXCR4 and Estrogen/Progesterone Receptor (ER/PR) pathway activity in Non Small Cell Lung Cancer (NSCLC)
15:10 - 15:27 | Author(s): S. Withecomb
- Abstract
Loading...
-
+
P2.03 - Poster Session 2 - Technology and Novel Development
- Type: Poster Session
- Track: Biology
- Presentations: 7
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.03-001 - Gene Expression Profile of A549 Cells from Tissue of 4D Model Predicts Poor Prognosis in Lung Cancer Patients
09:30 - 09:30 | Author(s): D.K. Mishra
- Abstract
Loading... -
+
P2.03-002 - Circulating Tumor Cells from 4D Model Mimic Metastatic Pattern in vivo and Gene Expression Profile Predicts Poor Prognosis in Lung Cancer Patients
09:30 - 09:30 | Author(s): D.K. Mishra
- Abstract
Loading... -
+
P2.03-003 - Two groups of lung adenocarcinoma cell lines that show distinct morphology and cancer-stromal interaction in 3 dimensional culture and mouse xenograft
09:30 - 09:30 | Author(s): T. Niki
- Abstract
Loading... -
+
P2.03-004 - Clinical application of targeted deep sequencing as a molecular screening for epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy in never-smoking lung adenocarcinoma
09:30 - 09:30 | Author(s): J. Han
- Abstract
Loading... -
+
P2.03-005 - Rotary Dissector: Frictional force achieved by using the porous polypropylene Rotary Dissector in clinical settings
09:30 - 09:30 | Author(s): J. Shimada
- Abstract
Loading... -
+
P2.03-006 - Determining Read Origin of Next-Generation Sequencing Datasets from Lung Cancer Xenografts
09:30 - 09:30 | Author(s): K. Marini
- Abstract
Loading... -
+
P2.03-007 - Changes in pulmonary immune cell recruitment and function during cigarette smoke-induced lung carcinogenesis in mice
09:30 - 09:30 | Author(s): R. Keith
- Abstract
Loading...
-
+
P2.04 - Poster Session 2 - Tumor Immunology
- Type: Poster Session
- Track: Biology
- Presentations: 3
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.04-001 - Myeloid derived suppressor cells (MDSC) are increased in patients with advanced non-squamous lung cancer (aNSQ) compared to healthy controls and early stage non-squamous lung cancer (eNSQ) and are related to the WHO performance status. Subanalysis of the NVALT12 study
09:30 - 10:30 | Author(s): J.G. Aerts
- Abstract
Loading... -
+
P2.04-002 - Differential expression of PD-L1, PD1 and CTLA4 receptor according to histology and tumour vs. surrounding non-malignant lung tissue in non-small cell lung cancer: RNA sequencing data
10:30 - 11:30 | Author(s): D. De Ruysscher
- Abstract
Loading... -
+
P2.04-003 - Novel mechanism of immune-tolerance due to aberrant expression of Natural Killer-Cell Immunoglobulin-like Receptors (KIRs) and enhanced platelet interactions
11:30 - 12:30 | Author(s): D.C. Chan
- Abstract
Loading...
-
+
P2.05 - Poster Session 2 - Preclinical Models of Therapeutics/Imaging
- Type: Poster Session
- Track: Biology
- Presentations: 27
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.05-001 - Recombinant human Apo2L/TRAIL (Dulanermin) in combination with carboplatin/pemetrexed in Malignant Pleural Mesothelioma (MPM): anticancer effects in vitro and in vivo.
09:30 - 09:30 | Author(s): G. Pasello
- Abstract
Loading... -
+
P2.05-002 - Resistance to BH3 mimetic S1 in SCLC cells that up-regulate and phosphorylate Bcl-2 through ERK1/2
09:30 - 09:30 | Author(s): Y. Liu
- Abstract
Loading... -
+
P2.05-003 - Regulation of SIRT2 for Human Non-Small Cell Lung Cancer Therapy
09:30 - 09:30 | Author(s): Z. Li
- Abstract
Loading... -
+
P2.05-004 - Synergistic antitumor activity of bevacizumab and erlotinib in EGFR-mutated non-small cell lung cancer xenograft models
09:30 - 09:30 | Author(s): Y. Moriya
- Abstract
Loading... -
+
P2.05-005 - Antitumor activity of bevacizumab in combination with docetaxel in EGFR-TKI resistant non-small cell lung cancer xenograft models.
09:30 - 09:30 | Author(s): K. Yorozu
- Abstract
Loading... -
+
P2.05-006 - Antitumor activity of bevacizumab in combination with pemetrexed as maintenance therapy for non-small cell lung cancer in a xenograft model: comparison with pemetrexed monotherapy and analysis of the combination mechanism
09:30 - 09:30 | Author(s): N. Ishikura
- Abstract
Loading... -
+
P2.05-007 - Significance of the recommended dose erlotinib for avoiding acquired resistance in NSCLC cells with exon19 deletion and L858R mutation of EGFR
09:30 - 09:30 | Author(s): K. Furugaki
- Abstract
Loading... -
+
P2.05-008 - Stem Cell transcription factors Oct4 and Nanog involved in chemoresistance and EGFR-TKI resistance of NSCLC
09:30 - 09:30 | Author(s): C. Su
- Abstract
Loading... -
+
P2.05-009 - Porphysome-enhanced bronchoscopic fluorescence detection and photothermal ablation of peripheral lung cancer: Preliminary in vivo studies
09:30 - 09:30 | Author(s): T. Anayama
- Abstract
Loading... -
+
P2.05-010 - Several receptor tyrosine kinase is activated but orchestrated by EGFR in EGFR-TKI acquired resistant lung adenocarcinoma cells with EGFR mutation
09:30 - 09:30 | Author(s): K. Suda
- Abstract
Loading... -
+
P2.05-011 - Characterisation of chemo-resistant syngeneic orthotopic rat pre-clinical models of mesothelioma.
09:30 - 09:30 | Author(s): A. Hudson
- Abstract
Loading... -
+
P2.05-012 - An inducible transition cell model reflecting epithelioid versus sarcomatoid differentiation of Malignant Pleural Mesothelioma
09:30 - 09:30 | Author(s): K. Schelch
- Abstract
Loading... -
+
P2.05-013 - Silencing the TUBB3 gene in vivo sensitises non-small cell lung cancer to cisplatin
09:30 - 09:30 | Author(s): M. Kavallaris
- Abstract
Loading... -
+
P2.05-014 - Schedule-dependent Interactions between Pemetrexed and Vinorelbine in Human Lung Cancer Cells
09:30 - 09:30 | Author(s): Z. Wang
- Abstract
Loading... -
+
P2.05-015 - A novel CRM1 inhibitor targeting for NSCLC with EGFR-TKI resistance mutation
09:30 - 09:30 | Author(s): S. Wang
- Abstract
Loading... -
+
P2.05-016 - Thoracoscopic Color and Fluorescence Imaging System for Sentinel Lymph Node Mapping in Porcine Lung Using Indocyanine Green-Neomannosyl Human Serum Albumin
09:30 - 09:30 | Author(s): H.K. Kim
- Abstract
Loading... -
+
P2.05-017 - Evaluation of the selective aurora B kinase inhibitor AZD1152 in SCLC lines with and without MYC family amplification.
09:30 - 09:30 | Author(s): B. Helfrich
- Abstract
Loading... -
+
P2.05-018 - Interferon-β efficiently inhibited endothelial progenitor cell-induced tumor angiogenesis
09:30 - 09:30 | Author(s): W.Y. Zhou
- Abstract
Loading... -
+
P2.05-019 - Therapeutic efficacy of DNA vaccine by targeting the mutant Kras in KrasG12D-induced lung cancer model
09:30 - 09:30 | Author(s): M. Yen
- Abstract
Loading... -
+
P2.05-020 - Combined gemcitabine and anti-CTLA4 therapy to target residual tumour following partial debulking surgery in a mouse mesothelioma model
09:30 - 09:30 | Author(s): A. Khong
- Abstract
Loading... -
+
P2.05-021 - Molecular analysis of asbestos-induced mesotheliomas from SV40 TAg transgenic mice shows that they are highly concordant with human mesothelioma
09:30 - 09:30 | Author(s): C. Robinson
- Abstract
Loading... -
+
P2.05-022 - Therapeutic potential of the FGFR Tyrosine Kinase Inhibitor, AZD4547 in Squamous non-small cell lung cancer
09:30 - 09:30 | Author(s): P. Gavine
- Abstract
Loading... -
+
P2.05-023 - In vivo micro-imaging of apoptosis in a murine xenograft model of human lung adenocarcinoma
09:30 - 09:30 | Author(s): F. Guisier
- Abstract
Loading... -
+
P2.05-024 - Prediction of drug sensitivity in second line treatment of patients with malignant pleural mesothelioma
09:30 - 09:30 | Author(s): J.M. Quispel-Janssen
- Abstract
Loading... -
+
P2.05-025 - Peptide-mediated Liposomal Doxorubicin Enhances Drug Delivery Efficiency and Therapeutic Efficacy in Lung Cancer Animal Models
09:30 - 09:30 | Author(s): H. Wu
- Abstract
Loading... -
+
P2.05-026 - A Development Drug Candidate Targeting EGFR Kinase for Lung Cancer: DBPR112
09:30 - 09:30 | Author(s): H. Hsieh
- Abstract
Loading... -
+
P2.05-027 - Generation and Biological Character Analysis of EGFR-TKI Resistant Cell Line
09:30 - 09:30 | Author(s): Y. Shi
- Abstract
Loading...
-
+
P2.06 - Poster Session 2 - Prognostic and Predictive Biomarkers
- Type: Poster Session
- Track: Biology
- Presentations: 50
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.06-001 - Introducing a novel RT-PCR assay for the detection of ROS1 fusion genes in NSCLC
09:30 - 09:30 | Author(s): M.K. Maus
- Abstract
Loading... -
+
P2.06-002 - Protein tyrosine kinase substrates profiling to detect short-term survivors in early stage lung adenocarcinoma
09:30 - 09:30 | Author(s): S. Arni
- Abstract
Loading... -
+
P2.06-003 - Clinical significance of detection of EGFR and KRAS mutations in plasma/pleural effusion in patients with advanced NSCLC
09:30 - 09:30 | Author(s): Z. Chen
- Abstract
Loading... -
+
P2.06-004 - Serum levels of MUC1 glycoprotein (ICO25) in primary lung cancer patients
09:30 - 09:30 | Author(s): T. Karmakova
- Abstract
Loading... -
+
P2.06-005 - The High Incidence of Overlap between Actionable Biomarkers in NSCLC: Potential Impact on Future Clinical Trial Design
09:30 - 09:30 | Author(s): D.S. Shames
- Abstract
Loading... -
+
P2.06-006 - Clinical and Prognostic Importance of XIAP and USP8 in Advanced Stages of Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): S. Buyukberber
- Abstract
Loading... -
+
P2.06-007 - Meta-Analysis of STAT3 and p-STAT3 Expression and Survival in Non-Small-Cell Lung Cancer
09:30 - 09:30 | Author(s): Y. Xu
- Abstract
Loading... -
+
P2.06-008 - Polymorphisms in the exon 20 of EGFR gene in metastatic lung adenocarcinoma: prognostic relevance and sensitivity to erlotinib.
09:30 - 09:30 | Author(s): G. Castro Jr.
- Abstract
Loading... -
+
P2.06-009 - Simultaneous Profiling of Multigene Mutations for the Effective And Efficient Diagnosis of Non-Small Cell Lung Carcinoma
09:30 - 09:30 | Author(s): B. Yu
- Abstract
Loading... -
+
P2.06-010 - Analytical Performance of the cobas EGFR Mutation Assay for Japanese Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): T. Ohira
- Abstract
Loading... -
+
P2.06-011 - Phosphorylated-Akt expression is a prognostic marker in early stage non-small cell lung cancer (NSCLC)
09:30 - 09:30 | Author(s): P.Y. Yip
- Abstract
Loading... -
+
P2.06-012 - Impact of EGFR T790M mutations and BIM mRNA expression on progression-free survival (PFS) and overall survival (OS) in patients with EGFR-mutant non-small-cell lung cancer (NSCLC) treated with erlotinib or chemotherapy in the randomized phase III EURTAC trial
09:30 - 09:30 | Author(s): R. Rosell
- Abstract
Loading... -
+
P2.06-013 - Genetic profiling of lung cancer in young adults patients: early data assessment using Next-Generation Sequencing.
09:30 - 09:30 | Author(s): T. Vavala'
- Abstract
Loading... -
+
P2.06-014 - Quantitative test of mutant EGFR and its effect on efficacy of EGFR TKI in advanced NSCLC
09:30 - 09:30 | Author(s): X. Li
- Abstract
Loading... -
+
P2.06-015 - Novel plasma proteins associated with prognosis in malignant pleural mesothelioma
09:30 - 09:30 | Author(s): S. Kao
- Abstract
Loading... -
+
P2.06-016 - Expression and clinical significance of the monocarboxylate transporter MCT1 as a novel therapeutic target in Small-Cell-Lung-Cancer (SCLC)
09:30 - 09:30 | Author(s): A. Fusi
- Abstract
Loading... -
+
P2.06-017 - Long non coding RNAs (lncRNAs) are dysregulated in malignant pleural mesothelioma (MPM)
09:30 - 09:30 | Author(s): C. Wright
- Abstract
Loading... -
+
P2.06-018 - Correlation of TS mRNA expression level and TS protein level detected by immunostaining for use in post-operative primary lung cancer therapy
09:30 - 09:30 | Author(s): N. Matsutani
- Abstract
Loading... -
+
P2.06-019 - EGFR mutation detection in ctDNA isolated from NSCLC patient plasma; a cross-platform comparison of leading technologies
09:30 - 09:30 | Author(s): K.S. Thress
- Abstract
Loading... -
+
P2.06-020 - Pretreatment thymidylate synthase protein expression levels remains stable during paclitaxel and carboplatin treatment in non-small cell lung cancer
09:30 - 09:30 | Author(s): J.N. Jakobsen
- Abstract
Loading... -
+
P2.06-021 - Is RRM1 a predictive marker for vinorelbine efficacy - the results from a cohort of malignant pleural mesotheliomas treated with cisplatin and vinorelbine.
09:30 - 09:30 | Author(s): Z.G. Zimling
- Abstract
Loading... -
+
P2.06-022 - Use of the Real-Time PCR and Multiplex Ligation-dependant Probe Amplification (MLPA) Assay in the Molecular Diagnosis for NSCLC biomarker detection.
09:30 - 09:30 | Author(s): J. Kowalewski
- Abstract
Loading... -
+
P2.06-023 - Gene expression signature and immunohistochemical assessment of NRF2 pathway activation for adjuvant chemotherapy benefit in lung squamous cell carcinoma (SqCC)
09:30 - 09:30 | Author(s): S. Sakashita
- Abstract
Loading... -
+
P2.06-024 - Prognostic value of RALA and RALB overexpression in KRAS mutant lung cancer
09:30 - 09:30 | Author(s): E.Y. Kim
- Abstract
Loading... -
+
P2.06-025 - Prognostic impact of CXCL16 and CXCR6 in two non-small cell lung cancer cohorts: combined high stromal and tumor cell CXCL16 expression yields an improved survival
09:30 - 09:30 | Author(s): S.M. Hald
- Abstract
Loading... -
+
P2.06-026 - Association of New York-Esophageal Antigen-1 (NY-ESO-1) promoter methylation and survival in stage III non-small cell lung cancer
09:30 - 09:30 | Author(s): M.S. Liew
- Abstract
Loading... -
+
P2.06-027 - Low frequency KRAS mutations in colorectal cancer patients and the presence of multiple mutations in oncogenic drivers in non-small cell lung cancer patients
09:30 - 09:30 | Author(s): L. Jiang
- Abstract
Loading... -
+
P2.06-028 - ERCC1 mRNA expression and KRAS mutation status in EGFR wild type (WT) advanced non-small cell lung cancer (NSCLC) patients
09:30 - 09:30 | Author(s): G. Metro
- Abstract
Loading... -
+
P2.06-029 - Alterations detected in glycerophospholipid profile of lung cancer tissue samples by mass spectrometry
09:30 - 09:30 | Author(s): A. Aug
- Abstract
Loading... -
+
P2.06-030 - Radiation-induced lung damage quantification with CT scans: Correlation with single nucleotide polymorphisms
09:30 - 09:30 | Author(s): D. De Ruysscher
- Abstract
Loading... -
+
P2.06-031 - Mutational profiling of synchronous bone metastases from lung adenocarcinoma: feasibility and results in a prospective cohort of 46 patients (POUMOS study)
09:30 - 09:30 | Author(s): M. Brevet
- Abstract
Loading... -
+
P2.06-033 - Identification f IGF-1R activation as a candidate molecular target in KRAS-mutated lung cancer
09:30 - 09:30 | Author(s): H. Mizuuchi
- Abstract
Loading... -
+
P2.06-034 - Analysis of Sensitivity of Lung Squamous Carcinoma with EGFR Mutation to EGFR-TKIs and Resistant Mechanism
09:30 - 09:30 | Author(s): Z. Wang
- Abstract
Loading... -
+
P2.06-035 - Acquired resistance in NSCLC with EGFR mutation treated with TKI's: Single center experience and treatment outcome
09:30 - 09:30 | Author(s): F.-. Griesinger
- Abstract
Loading... -
+
P2.06-036 - DNA Damage Response during Curative Radiotherapy of Non-Small Cell Lung Cancer: In-Vivo Biodosimetry with Peripheral Blood Lymphocytes and Systemic Effects Measured in Hair Follicles
09:30 - 09:30 | Author(s): S. Siva
- Abstract
Loading... -
+
P2.06-037 - Transforming growth factor-β1 genetic polymorphisms relate to erlotinib induced diarrheaTransforming growth factor-β1 genetic polymorphisms relate to erlotinib induced diarrheaTransforming growth factor-β1 genetic polymorphisms relate to erlotinib induced diarrhea
09:30 - 09:30 | Author(s): T. Kimura
- Abstract
Loading... -
+
P2.06-038 - Comparison of expression profiling of circulating and tissue miRNAs looking for possible non-invasive biomarkers for the treatment of metastatic NSCLC patients: preliminary results.
09:30 - 09:30 | Author(s): S. Tommasi
- Abstract
Loading... -
+
P2.06-039 - The Status of Epidermal Growth Factor Rceptor (EGFR) Mutation, Protein Overexpression and Gene Amplification in Esophageal Squamous Cell Carcinomas
09:30 - 09:30 | Author(s): Y. Xu
- Abstract
Loading... -
+
P2.06-040 - Circulating cytokines and angiogenic factors (CAFs) as markers of clinical response in a randomized phase II study of trametinib vs docetaxel for patients with KRAS-mutant non-small cell lung cancer (NSCLC) (MEK114653, NCT01362296)
09:30 - 09:30 | Author(s): H.T. Tran
- Abstract
Loading... -
+
P2.06-041 - Plasma Vascular endothelial growth factor 165(VEGF 165) in advanced Non-small cell lung cancer
09:30 - 09:30 | Author(s): A. Abdallah
- Abstract
Loading... -
+
P2.06-042 - Thymidylate synthase expression as predictive biomarker of pemetrexed sensitivity in advanced thoracic cancer patients.
09:30 - 09:30 | Author(s): M. Domine
- Abstract
Loading... -
+
P2.06-043 - CYP1A1*2A Polymorphism is correlate with EGFR Exon 19 Mutation and is an Independent Prognostic indicator for the Advanced Lung Cancer Patients Treated with EGFR-TKI
09:30 - 09:30 | Author(s): Q. Nie
- Abstract
Loading... -
+
P2.06-044 - The influence of TP53 mutation on the prognosis of patients with early
stage non-small cell lung cancer may depend on the intratumor
heterogeneity of the mutation09:30 - 09:30 | Author(s): S.Y. Lee
- Abstract
Loading... -
+
P2.06-045 - c-Met Expression in Malignant Mesotheliomas
09:30 - 09:30 | Author(s): P. Illei
- Abstract
Loading... -
+
P2.06-046 - EML4-ALK monitoring of crizotinib response in blood platelets and plasma of NSCLC patients
09:30 - 09:30 | Author(s): J. Nilsson
- Abstract
Loading... -
+
P2.06-047 - BLOCker Sequencing - An Improvement in Sanger Sequencing which Supercharges Low Level Mutation Detection
09:30 - 09:30 | Author(s): B. Legendre, Jr.
- Abstract
Loading... -
+
P2.06-048 - Malignant mesothelioma lacking merlin shows enhanced sensitivity to the FAK Inhibitor VS-6063: Evaluation of merlin/NF2 status in clinical samples
09:30 - 09:30 | Author(s): M. Keegan
- Abstract
Loading... -
+
P2.06-049 - TTF1 negative status is a negative predictor of benefit to Erlotinib (E) in metastatic Non Small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Author(s): H. Charalambous
- Abstract
Loading... -
+
P2.06-050 - Validation and Utilization of a Clinical Next Generation Sequencing Assay to identify Mutations and Genomic Copy number changes in Lung Cancer
09:30 - 09:30 | Author(s): R. Daber
- Abstract
Loading... -
+
P2.06-051 - Clinical significance of pretreatment plasma biomarkers in advanced non-small cell lung cancer patients
09:30 - 09:30 | Author(s): X. Han
- Abstract
Loading...
-
+
P2.07 - Poster Session 2 - Surgery
- Type: Poster Session
- Track: Surgery
- Presentations: 49
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.07-001 - Long-Term Lung Cancer Survivors Have Permanently Decreased Quality of Life Following Surgery
09:30 - 09:30 | Author(s): I. Ilonen
- Abstract
Loading... -
+
P2.07-002 - Sentinel node biopsy reduces the need for systematic mediastinal lymphadenectomy in stage IA NSCLC
09:30 - 09:30 | Author(s): J. Juricic
- Abstract
Loading... -
+
P2.07-003 - Sampling vs. systematic full lymphatic dissection in surgical treatment of non-small cell lung cancer
09:30 - 09:30 | Author(s): K.N. Syrigos
- Abstract
Loading... -
+
P2.07-004 - Wedge Resection and Segmentectomy in Patients with Stage I Non-small Cell Lung Cancer
09:30 - 09:30 | Author(s): K.N. Syrigos
- Abstract
Loading... -
+
P2.07-005 - A comparative study of diagnosing and staging by mediastinoscopy or EBUS on lung cancer
09:30 - 09:30 | Author(s): Y. Shen-Tu
- Abstract
Loading... -
+
P2.07-006 - Predicting factors for early and long term mortality and complications after thoracotomy in patients with primary lung cancer
09:30 - 09:30 | Author(s): C.V. Arkel
- Abstract
Loading... -
+
P2.07-007 - Surgical treatment of elderly patients with resectable lung cancer
09:30 - 09:30 | Author(s): Y. Kawaguchi
- Abstract
Loading... -
+
P2.07-008 - Radiological-pathological correlation for resected small lung nodules with pure ground glass opacity detected by high-resolution computed tomography
09:30 - 09:30 | Author(s): M. Yamaguchi
- Abstract
Loading... -
+
P2.07-009 - What is an appropriate treatment strategy for superior sulcus tumors?
09:30 - 09:30 | Author(s): T. Tsukioka
- Abstract
Loading... -
+
P2.07-010 - surgical treatment and outcome of multiple primary lung cancers
09:30 - 09:30 | Author(s): S. Saito
- Abstract
Loading... -
+
P2.07-011 - A pilot study on the effects of perioperartive administration of the neutrophil elastase inhibitor, Sivelestat, to non-small cell lung cancer patients with preoperative risk factors of acute respiratory distress syndrome after pulmonary resection
09:30 - 09:30 | Author(s): T. Kometani
- Abstract
Loading... -
+
P2.07-012 - Long-term results of limited resection for small adenocarcinoma showing ground-glass opacity
09:30 - 09:30 | Author(s): T. Watanabe
- Abstract
Loading... -
+
P2.07-013 - Risk factors for locoregional failure in completely resected N1 non-small cell lung cancer without postoperative radiotherapy
09:30 - 09:30 | Author(s): S. Cho
- Abstract
Loading... -
+
P2.07-014 - Intrapleural Perfusion Hyperthermic Chemotherapy in Malignant Pleural Effusion and Pleural Seeding
09:30 - 09:30 | Author(s): D. Noh
- Abstract
Loading... -
+
P2.07-015 - Clinical outcome of 16 extremely elder patients (85-year-old or over) with surgically resected non-small cell lung cancer
09:30 - 09:30 | Author(s): T. Yoshioka
- Abstract
Loading... -
+
P2.07-016 - Perioperative nutrition of induction chemoradiotherapy followed by surgery in locally advanced non-small lung cancer patients
09:30 - 09:30 | Author(s): J. Soh
- Abstract
Loading... -
+
P2.07-017 - Pulmonary Resection for Lung Cancer Patients with Cerebrovascular and Cardiovascular Comorbidities
09:30 - 09:30 | Author(s): N. Izumi
- Abstract
Loading... -
+
P2.07-018 - Curative Surgery In Lung Cancer: Cases Presented At Multidisciplinary Meetings Compared With A Contemporaneous Control Group.
09:30 - 09:30 | Author(s): P.J.T. Bowers
- Abstract
Loading... -
+
P2.07-019 - Postoperative Outcome of Patients with Pulmonary Large-cell Neuroendocrine Carcinoma
09:30 - 09:30 | Author(s): T. Koike
- Abstract
Loading... -
+
P2.07-020 - Clinicopathological characteristics of patients with unexpected pathological N1 and N2 lung cancer
09:30 - 09:30 | Author(s): T. Haruki
- Abstract
Loading... -
+
P2.07-021 - Results of surgical treatment for lung cancer in patients aged 80 years or over - Single institution over 20 year experience
09:30 - 09:30 | Author(s): T. Miyazaki
- Abstract
Loading... -
+
P2.07-022 - Prognostic Implication of Cytodiagnosis of Minute Pleural Effusion found at Thoracotomy in NSCLC Patients
09:30 - 09:30 | Author(s): M. Shiba
- Abstract
Loading... -
+
P2.07-023 - Extended sleeve lobectomy after induction chemoradiotherapy for locally advanced non-small cell lung cancer
09:30 - 09:30 | Author(s): H. Yamamoto
- Abstract
Loading... -
+
P2.07-024 - Predictive factors for postoperative morbidity in patients undergoing esophagectomy for esophageal cancer:
09:30 - 09:30 | Author(s): S. Krishnamurthy
- Abstract
Loading... -
+
P2.07-025 - New pathological classification of lung adenocarcinoma is useful for selecting limited cases undergoing sublobar resection as a curative surgery.
09:30 - 09:30 | Author(s): A. Shimamoto
- Abstract
Loading... -
+
P2.07-026 - Does surgeon grade influence early postoperative outcomes in major resection for lung tumors?
09:30 - 09:30 | Author(s): C.S. Pramesh
- Abstract
Loading... -
+
P2.07-027 - Retrospective Analysis of 236 Consecutive Robotic-Assisted Pulmonary Lobectomies at a Single Institution: A Bi-Phasic Learning Curve
09:30 - 09:30 | Author(s): K.L. Rodriguez
- Abstract
Loading... -
+
P2.07-028 - ProvenCare®: Evidence Based Care to Optimize Lung Cancer Resection Outcomes
09:30 - 09:30 | Author(s): N.M. Korgaonkar
- Abstract
Loading... -
+
P2.07-029 - Clinical features and outcome of surgically resected secondary primary non-small cell lung cancer
09:30 - 09:30 | Author(s): M. Kakihana
- Abstract
Loading... -
+
P2.07-030 - The Role of Mediastinal Lymph Node Dissection during Pulmonary Metastasectomy in Patients with No Evidence of Mediastinal Lymph Node Metastasis Based on Preoperative Computed Tomography and Positron Emission Tomography
09:30 - 09:30 | Author(s): J.Y. Kim
- Abstract
Loading... -
+
P2.07-031 - Locally advanced lung cancer with low nodal involvement and concomitant tuberculosis in a tertiary care cancer centre of India
09:30 - 09:30 | Author(s): P. Ramanathan
- Abstract
Loading... -
+
P2.07-032 - Video-Assisted Thoracic Surgery versus Open Thoracotomy for Non-Small Cell Lung Cancer - A Meta-analysis of Propensity Score Matched Patients
09:30 - 09:30 | Author(s): C. Cao
- Abstract
Loading... -
+
P2.07-033 - A comparative study of complete video-assisted thoracoscopic lobectomy and video-assisted mini-thoracotomy in treatment of lung cancer
09:30 - 09:30 | Author(s): Y. Zhang
- Abstract
Loading... -
+
P2.07-034 - Audit of mediastinal lymph node (MLN) examination in non-small cell lung cancer (NSCLC) resections using a specimen collection kit and checklist intervention.
09:30 - 09:30 | Author(s): R.U. Osarogiagbon
- Abstract
Loading... -
+
P2.07-035 - Comparison of Cancer-Specific Outcomes between Open and Minimally Invasive Surgery (MIS) Lobectomy for Early Stage Non-Small-Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Author(s): C.L. Wilshire
- Abstract
Loading... -
+
P2.07-036 - Lower-than-expected FEV1 after upper lobe resection for lung cancer in the early postoperative period
09:30 - 09:30 | Author(s): Y. Hirami
- Abstract
Loading... -
+
P2.07-037 - Minimally invasive anatomic segmentectomy as primary treatment for lung lesions
09:30 - 09:30 | Author(s): E.R. Júnior
- Abstract
Loading... -
+
P2.07-038 - Elderly patients with non-small cell lung cancer are often not operated on - Results from a population-based study
09:30 - 09:30 | Author(s): T. Gudbjartsson
- Abstract
Loading... -
+
P2.07-039 - Survival outcome of Patients undergoing Surgical Resection of NSCLC in Brunei Darussalam
09:30 - 09:30 | Author(s): C.F. Chong
- Abstract
Loading... -
+
P2.07-040 - Is postoperative FEV1 (poFEV1) more accurately estimated by Functional Respiratory Imaging (FRI) than by conventional methods?
09:30 - 09:30 | Author(s): A. Janssens
- Abstract
Loading... -
+
P2.07-041 - Talc pleurodesis or IPC for malignant pleural effusion. Is it Time to change?
09:30 - 09:30 | Author(s): A.J. Sharkey
- Abstract
Loading... -
+
P2.07-042 - Is plasma fibrinogen a novel independent prognostic factor in patients undergoing surgery for Non-Small Cell Lung Cancer?
09:30 - 09:30 | Author(s): M.O. Smith
- Abstract
Loading... -
+
P2.07-043 - Effect of Female Gender on Peri-Operative Outcomes after Robotic-Assisted Pulmonary Lobectomy: Retrospective Analysis of 180 Consecutive Cases
09:30 - 09:30 | Author(s): F.O. Velez-Cubian
- Abstract
Loading... -
+
P2.07-044 - Risk factors for recurrence after pathological stage IA non-small cell lung cancer resection
09:30 - 09:30 | Author(s): Y. Otani
- Abstract
Loading... -
+
P2.07-045 - Post lung surgery rehabilitation
09:30 - 09:30 | Author(s): S. Petersen
- Abstract
Loading... -
+
P2.07-046 - Effect of airway stenting on quality of life (QoL) in patients with malignant airway obstruction: A single institutional experience at Mayo Clinic Arizona (MCA)
09:30 - 09:30 | Author(s): H.R. Paripati
- Abstract
Loading... -
+
P2.07-047 - A New Minimally Invasive Surgical Technique to Access a Fused Pleural Space for Biopsy, Gene Therapy or Other Novel Intrapleural Therapeutics - A Report of 34 Patients
09:30 - 09:30 | Author(s): J. Friedberg
- Abstract
Loading... -
+
P2.07-048 - Causes, predictors and consequences of conversions in VATS lobectomy for NSCLC
09:30 - 09:30 | Author(s): J. Bodner
- Abstract
Loading... -
+
P2.07-050 - Short term preoperative efficacy of tiotropium for patients with resectable lung cancer and chronic obstractive pulmonary disease: Preliminary results of one arm prospective study
09:30 - 09:30 | Author(s): T. Matsunaga
- Abstract
Loading...
first
prev
